Details of the Drug Formulations

General Information of Drug (ID: DMTWS9E)

Drug Name
Apremilast Drug Info
Synonyms Apremilast (USAN); CC-10004; N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Approved [1]
Psoriatic arthritis FA21 Approved [2]
Cross-matching ID
PubChem CID
11561674
ChEBI ID
CHEBI:78540
CAS Number
608141-41-9
TTD ID
D07ESC
VARIDT ID
DR01264
INTEDE ID
DR0124
ACDINA ID
D00041

Full List of Drug Formulations Containing This Drug

Apremilast 30 mg tablet
Company Formulation ID FDA Description
Celgene Corporation F01371 Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7372).
2 Apremilast FDA Label